2025-07-05 - Analysis Report
Okay, here's an analysis of Honeywell International Inc (HON), incorporating all the data provided, structured for clarity, and including concise summaries:

**Executive Summary**

Honeywell International Inc. (HON) is a diversified technology and manufacturing company.  Its stock performance has lagged the S&P 500 recently.  While some risk indicators suggest medium risk, recent news indicates volatility, and expert advice suggests monitoring announcements. Recent earnings are stable. In summary, given the slightly overheated RSI, it is not the optimal time to buy more, but the long-term outlook is expected to outperform the S&P500, so maintaining the current position may be a good strategy

---

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (HON):** 53.11%
*   **Cumulative Return (VOO):** 95.42%
*   **Absolute Deviation:** -44.9%
*   **Relative Deviation:** 7.0% (This means HON's underperformance is near the low end of its historical range relative to VOO.)

**Analysis:**

HON has significantly underperformed the S&P 500 over the observed period. The relative deviation suggests that while the underperformance is substantial, it's not unprecedented historically.

**Alpha/Beta Analysis:**

| Year       | CAGR     | MDD     | Alpha   | Beta   | Cap(B) |
|------------|----------|---------|---------|--------|--------|
| 2015-2017  | 38.0%    | 56.2%   | 9.0%    | 0.1    | 94.5   |
| 2016-2018  | 22.0%    | 63.2%   | 4.0%    | 0.1    | 85.0   |
| 2017-2019  | 42.0%    | 63.2%   | 13.0%   | 0.5    | 113.9  |
| 2018-2020  | 51.0%    | 63.2%   | 31.0%   | 0.3    | 136.8  |
| 2019-2021  | 48.0%    | 59.4%   | 0.0%    | 0.2    | 134.1  |
| 2020-2022  | 34.0%    | 70.8%   | 31.0%   | 0.2    | 137.8  |
| 2021-2023  | -10.0%   | 70.8%   | -28.0%  | 0.6    | 134.9  |
| 2022-2024  | -21.0%   | 71.7%   | -47.0%  | 0.6    | 145.3  |
| 2023-2025  | -17.0%   | 71.7%   | -64.0%  | 1.1    | 154.6  |

**Analysis:**

*   **CAGR:** Fluctuates significantly, showing inconsistent growth rates.
*   **MDD (Maximum Drawdown):**  Consistently high, indicating substantial risk of loss during downturns.
*   **Alpha:** The alpha values are quite varied, but generally show a decreasing trend in recent periods, indicating underperformance relative to its risk-adjusted benchmark. Note that in the last three periods (2021-2025) show significant underperformance.
*   **Beta:** Generally low (below 1), meaning HON is theoretically less volatile than the overall market (S&P 500). However, the recent period shows increased beta (1.1), indicating higher sensitivity to market movements.  Be careful!
*   **Cap(B):** Market capitalization has generally increased over time, suggesting growth in company size.

---

**2. Recent Price Action**

*   **Current Price:** 240.40
*   **Previous Close:** 239.26
*   **Change:** 0.48 (+0.48%)
*   **5-day Moving Average:** 236.30
*   **20-day Moving Average:** 227.68
*   **60-day Moving Average:** 217.00

**Analysis:**

The stock is trading above all three moving averages, suggesting a short-term uptrend. The price change from the previous close is a positive sign, and the fact that the 5-day moving average is above the 20-day and 60-day moving averages reinforces this trend.

---

**3. Technical Indicators & Outlook**

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 74.45 (Overbought)
*   **PPO:** 0.637
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Deviation Change:** -0.6 (Decreasing - short-term decline)
*   **Expected Return (%):** -29.4% (Over 2 years vs. S&P 500)

**Analysis:**

*   **MRI:** Suggests a low-risk environment.
*   **RSI:**  The RSI indicates that the stock is currently overbought, which could suggest a potential pullback or consolidation in the near term.
*   **PPO:** Positive but relatively low, suggesting momentum is positive but not exceptionally strong.
*   **Hybrid Signal:**  The hybrid signal suggests caution despite the low MRI, recommending buying 80% of cash with caution
*   **Relative Deviation Change:** The negative change indicates that HON's underperformance relative to the S&P 500 has worsened recently.
*   **Expected Return:** The negative expected return indicates that, based on current analysis, HON is projected to underperform the S&P 500 over the next two years.

---

**4. Recent News & Events**

*   **2025-07-04:** Major business developments, regulatory changes, or market events impacting HON.
*   **2025-07-01:** Analyst discussions on HON's performance and outlook.
*   **2025-07-05:** Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **2025-07-03:** Market experts highlight both risks and opportunities, advising monitoring of news and announcements.

**Analysis:**

Recent news suggests HON is experiencing volatility and is subject to ongoing analysis and market scrutiny.  Investors should monitor news closely for any significant developments.

---

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-04-29 | 2.24 | 9.82 B$    |
| 2024-10-24 | 2.17 | 9.73 B$    |
| 2024-07-25 | 2.37 | 9.58 B$    |
| 2024-04-25 | 2.24 | 9.11 B$    |
| 2025-04-29 | 2.24 | 9.11 B$    |

**Analysis:**

*   EPS and revenue have been relatively stable.

---

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $9.82B    | 38.54%        |
| 2024-12-31   | $10.09B   | 36.38%        |
| 2024-09-30   | $9.73B    | 38.54%        |
| 2024-06-30   | $9.58B    | 38.85%        |
| 2024-03-31   | $9.11B    | 38.68%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-03-31   | $17.46B   | 8.30%  |
| 2024-12-31   | $18.62B   | 6.90%  |
| 2024-09-30   | $17.41B   | 8.12%  |
| 2024-06-30   | $16.95B   | 9.11%  |
| 2024-03-31   | $16.45B   | 8.89%  |

**Analysis:**

*   **Revenue:** Shows a slight upward trend over the past year.
*   **Profit Margin:** Relatively consistent, indicating strong operational efficiency.
*   **Equity:** Fluctuates, with a recent slight decrease.
*   **ROE (Return on Equity):** Indicates a decent return on shareholder equity but has decreased slightly in the most recent quarter.

---

**7. Overall Summary & Recommendation**

Honeywell (HON) presents a mixed picture. While its revenue and profit margins are stable and the MRI indicates low risk, it has significantly underperformed the S&P 500, and its expected future return is negative compared to the index. The RSI suggests the stock is currently overbought, indicating a potential short-term pullback.

**Given the slightly overheated RSI, it is not the optimal time to buy more, but the long-term outlook is expected to outperform the S&P500, so maintaining the current position may be a good strategy.** You should closely monitor news and events surrounding Honeywell and re-evaluate your position based on further developments.
